Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 12/20 | 0.77 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | HTR7 | P34969 | 1/20 | 0.47 |
| ▸ | CNR1 | P21554 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4425316 | 0.90 | SLC6A9 (0.81) | SLC6A9KCNH2ALDH1A1HTTGPR55 | |
| SCHEMBL4422319 | 0.87 | SLC6A9 (1.00) | SLC6A9KCNH2GPR55 | |
| SCHEMBL3920951 | 0.85 | SLC6A9 (0.75) | SLC6A9KCNH2CNR1ALDH1A1HTT | |
| SCHEMBL3928202 | 0.82 | SLC6A9 (0.77) | SLC6A9 | |
| SCHEMBL4435392 | 0.82 | SLC6A9 (0.92) | SLC6A9KCNH2GPR55 | |
| SCHEMBL4426854 | 0.80 | SLC6A9 (0.85) | SLC6A9KCNH2GPR55 | |
| SCHEMBL5037924 | 0.79 | SLC6A9 (0.60) | SLC6A9KCNH2 | |
| SCHEMBL4424645 | 0.79 | SLC6A9 (0.85) | SLC6A9KCNH2GPR55 | |
| SCHEMBL4426303 | 0.79 | SLC6A9 (0.84) | SLC6A9KCNH2GPR55 | |
| SCHEMBL4422354 | 0.79 | SLC6A9 (1.00) | SLC6A9KCNH2GPR55 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005023261-A1 | 1-BENZOYL-PIPERAZINE DERIVATIVES AS GLYCINE UPTAKE INHIBITORS FOR THE TREATMENT OF PSYCHOSES | F. HOFFMANN-LA ROCHE AG (CH) | 2005-03-17 | — | — | WO | disclosed |